Loading...
Market
Which country will first approve CDO-7N-1 antibody for COVID-19 treatment by December 31, 2024?
2
Resolution / Starting Odds
United States • 25%
United Kingdom • 25%
European Union • 25%
Other • 25%
Official announcements from relevant health authorities of the countries
Story
Texas Biomed Discovers Antibody CDO-7N-1 Neutralizing All COVID-19 Variants
Sep 10, 2024, 12:27 PM
Researchers at Texas Biomed have discovered an antibody, CDO-7N-1, that can neutralize all known variants of SARS-CoV-2, the virus responsible for COVID-19. This antibody induces immunity to all major SARS-CoV-2 proteins and is highly effective against all major variants to date. Additionally, the antibody has shown effectiveness against distantly related SARS-like coronaviruses that infect other animals. This breakthrough could have significant implications for the treatment and prevention of COVID-19 and related viral infections.
View original story
Similar markets
United States • 25%
United Kingdom • 25%
European Union • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
European Union • 25%
Other • 25%
UK • 14%
USA • 14%
Germany • 14%
France • 14%
Japan • 14%
Australia • 14%
Other • 14%
United States • 25%
United Kingdom • 25%
Australia • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
India • 25%
South Africa • 25%
Brazil • 25%
Other • 25%
United States • 25%
Canada • 25%
United Kingdom • 25%
Other • 25%
USA • 25%
EU • 25%
Canada • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
USA • 25%
UK • 25%
Germany • 25%
Other • 25%
UK • 14%
Germany • 14%
USA • 14%
France • 14%
Italy • 14%
Spain • 14%
Other • 14%